MedPath

Evaluation of Combination Nano micelle Curcumin with Triamcinolone Acetonide in Oral Lichen planus

Phase 3
Conditions
Oral Lichen Planus.
Lichen Planus
Registration Number
IRCT20190523043678N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Patients with sympathetic lichen planus (erosive or atrophic) with burning or pain
Clinical diagnosis (Wicham lines) and in cases where it was difficult to achieve a definitive diagnosis of the lesion, a histopathologic evaluation was used
The patient has not been taking topical corticosteroid therapy over the past two weeks, he has not used systemic corticosteroids during the past month.
The patient has not used Analgesic and anestheticpain

Exclusion Criteria

Patients with lichenoid lesions caused by drugs or dental materials
pregnant or lactation
Patients who have other lesions similar to systemic leukoplakia and systemic lupus in conjunction with lichen planus
Historh of malignancy
Non-cooperative patients and patients who do not take medication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity and size of the lesion. Timepoint: Base Day (0), Day 14, Day 28. Method of measurement: with a scaled abslang.;Reduction in severity of lessions. Timepoint: Base Day (0), Day 14, Day 28. Method of measurement: Efficacy Index.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath